F. J. van Sprang

885 total citations
30 papers, 619 citations indexed

About

F. J. van Sprang is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, F. J. van Sprang has authored 30 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Clinical Biochemistry, 17 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in F. J. van Sprang's work include Metabolism and Genetic Disorders (23 papers), Amino Acid Enzymes and Metabolism (9 papers) and Mitochondrial Function and Pathology (6 papers). F. J. van Sprang is often cited by papers focused on Metabolism and Genetic Disorders (23 papers), Amino Acid Enzymes and Metabolism (9 papers) and Mitochondrial Function and Pathology (6 papers). F. J. van Sprang collaborates with scholars based in Netherlands, United States and Germany. F. J. van Sprang's co-authors include S.K. Wadman, M. Durán, L. Dorland, D. Ketting, P.K. De Bree, Lodewijk IJlst, Colin van der Heiden, Karlien Cransberg, C. Jakobs and O. P. van Diggelen and has published in prestigious journals such as The Lancet, Electroencephalography and Clinical Neurophysiology and Clinica Chimica Acta.

In The Last Decade

F. J. van Sprang

29 papers receiving 587 citations

Peers

F. J. van Sprang

PHYSI

BIOCH

PPCH

E A Burgess United Kingdom

B. M. Tracey United Kingdom

Hans‐Christoph Curtius Switzerland

M. Blaskovics United States

R. Baumgartner Switzerland

D. Leupold Germany

S. K. Wadman Netherlands

Takenobu Kamada Japan

H Ozasa Japan

Claude Sansaricq United States

E A Burgess United Kingdom

F. J. van Sprang

380 ×1.1

331 ×0.9

146 ×0.8

PHYSI

128 ×1.6

BIOCH

95 ×1.3

PPCH

Citations per year, relative to F. J. van Sprang F. J. van Sprang (= 1×) peers E A Burgess

Countries citing papers authored by F. J. van Sprang

Since Specialization

Citations

This map shows the geographic impact of F. J. van Sprang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. J. van Sprang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. J. van Sprang more than expected).

Fields of papers citing papers by F. J. van Sprang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. J. van Sprang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. J. van Sprang. The network helps show where F. J. van Sprang may publish in the future.

Co-authorship network of co-authors of F. J. van Sprang

This figure shows the co-authorship network connecting the top 25 collaborators of F. J. van Sprang. A scholar is included among the top collaborators of F. J. van Sprang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. J. van Sprang. F. J. van Sprang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Durán, M., C.B.J.M. Cleutjens, D. Ketting, et al.. (1992). Diagnosis of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Lymphocytes and Liver by a Gas Chromatographic Method: The Effect of Oral Riboflavin Supplementation. Pediatric Research. 31(1). 39–42. 23 indexed citations

Durán, M., Ronald J. A. Wanders, L. Dorland, et al.. (1991). 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment. European Journal of Pediatrics. 150(3). 190–195. 64 indexed citations

Wanders, Ronald J. A., R. B. H. Schutgens, J. B. C. de Klerk, et al.. (1990). Rapid diagnosis of 3-hydroxy-3-methylglutaryl—coenzyme A lyase deficiency via enzyme activity measurements in leukocytes or platelets using a simple spectrophotometric method. Clinica Chimica Acta. 189(3). 327–334. 9 indexed citations

Wanders, R. J. A., Lodewijk IJlst, A. H. van Gennip, et al.. (1990). Long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: Identification of a new inborn error of mitochondrial fatty acidβ‐oxidation. Journal of Inherited Metabolic Disease. 13(3). 311–314. 106 indexed citations

Gibson, K. Michael, William L. Nyhan, L. Sweetman, et al.. (1988). 3-Methylglutaconic aciduria: a phenotype in which activity of 3-methylglutaconyl-coenzyme A hydratase is normal. European Journal of Pediatrics. 148(1). 76–82. 21 indexed citations

Dorland, L., et al.. (1988). Disorders of Amino Acid Metabolism. Scandinavian Journal of Clinical and Laboratory Investigation. 48(sup190). 75–77. 5 indexed citations

Klerk, J. B. C. de, et al.. (1988). Disorders of Amino Acid Metabolism. Scandinavian Journal of Clinical and Laboratory Investigation. 48. 75–77.

Klerk, J. B. C. de, et al.. (1988). Disorders of Organic Acid Metabolism. Scandinavian Journal of Clinical and Laboratory Investigation. 48. 78–78. 2 indexed citations

Dorland, L., M. Durán, Jan N. Breg, et al.. (1988). β-Mannosidosis in Two Brothers with Hearing Loss. PubMed. 11 Suppl 2. 255–258. 52 indexed citations

10.

Sprang, F. J. van, et al.. (1986). A patient with sarcosinaemia. Journal of Inherited Metabolic Disease. 9(4). 404–405. 1 indexed citations

11.

Wadman, S.K., F. A. Beemer, P.K. De Bree, et al.. (1984). New Defects of Pyrimidine Metabolism. Advances in experimental medicine and biology. 165 Pt A. 109–114. 22 indexed citations

12.

Durán, M., D. Ketting, P.K. De Bree, et al.. (1981). A case of formiminoglutamic aciduria. European Journal of Pediatrics. 136(3). 319–323. 2 indexed citations

13.

Sprang, F. J. van, et al.. (1979). Computer analysis of the EEG as an aid in the evaluation of dietetic treatment in phenylketonuria. Electroencephalography and Clinical Neurophysiology. 46(2). 205–213. 17 indexed citations

14.

Heiden, Colin van der, Marcel R.M. van den Brink, P.K. De Bree, et al.. (1978). Familial hyperlysinaemia due to L‐lysineα‐ketoglutarate reductase deficiency: Results of attempted treatment. Journal of Inherited Metabolic Disease. 1(3). 89–94. 10 indexed citations

15.

Wadman, S.K., P.K. De Bree, F. J. van Sprang, et al.. (1975). Nϵ-(carboxymethyd)lysine, a constituent of human urine. Clinica Chimica Acta. 59(3). 313–320. 44 indexed citations

16.

Bakker, H. D., S.K. Wadman, F. J. van Sprang, et al.. (1975). Tyrosinemia and tyrosyluria in healthy prematures: Time courses not vitamin C-dependent. Clinica Chimica Acta. 61(1). 73–90. 7 indexed citations

17.

Bakker, H. D., P.K. De Bree, D. Ketting, F. J. van Sprang, & S.K. Wadman. (1974). Fructose-1,6-diphosphatase deficiency: Another enzyme defect which can present itself with the clinical features of “tyrosinosis”. Clinica Chimica Acta. 55(1). 41–47. 6 indexed citations

18.

Wadman, S.K., Colin van der Heiden, D. Ketting, & F. J. van Sprang. (1971). Abnormal tyrosine and phenylalanine metabolism in patients with tyrosyluria and phenylketonuria; gas-liquid chromatographic analysis of urinary metabolites. Clinica Chimica Acta. 34(2). 277–287. 44 indexed citations

19.

Wadman, S.K., P.K. De Bree, Colin van der Heiden, & F. J. van Sprang. (1971). Automatic column chromatographic analysis of urinary and serum imidazoles in patients with histidinaemia and normals. Clinica Chimica Acta. 31(1). 215–224. 19 indexed citations

20.

Sprang, F. J. van & S.K. Wadman. (1967). Treatment of a Patient with Histidinemia. Acta Paediatrica. 56(5). 493–497. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact